可的松与皮质类固醇注射 资料

本页面由机器翻译,尚未经临床医生审核。英文版本为权威版本。

什么是

可的松注射是将一种称为皮质类固醇的强效抗炎药物注射到疼痛的关节或肌腱中。这种药物能在局部消除肿胀、缓解疼痛。它不是口服止痛药,而是在注射的部位发挥作用。

对于多种手部、腕部、肘部和肩部问题,医生可能会建议这种治疗。这些问题包括扳机指(手指屈伸时卡住或锁住)、腕管综合征(腕部的神经受压)、网球肘、拇指根部关节炎、冻结肩(肩周炎)以及某些腱鞘囊肿。它也可用于某些肩部手术之后,但通常不会在术后第一个月内使用 [1]。

注射并不能解决根本问题。它的作用是在身体自我修复期间,或在您进行锻炼、佩戴支具期间,为您争取一段缓解期。以腕管综合征为例,注射可以暂时缓解症状,但大多数人最终需要手术才能长期控制病情 [2]。对于网球肘,短期的缓解效果可能会逐渐消退,问题也常常在之后复发 [3]。医生会和您讨论注射是否适合您的情况,或者是否应先尝试锻炼、支具或手术等其他方案。

它有效吗?

坦白地说:这取决于所治疗的病症。

对于某些问题,注射效果很好。对于冻结肩,向关节内注射类固醇可以缓解疼痛、改善肩部功能并增加活动范围 [4]。对于狭窄性腱鞘炎(de Quervain病,拇指根部的肌腱肿胀),注射后疼痛和临床效果都有明显改善 [5]。对于拇指根部关节炎,类固醇是一种较好的选择,因为它操作简便、效果良好 [6],不过其益处可能只是短期的 [7]。

对于另一些问题,情况则更为复杂。对于网球肘,类固醇注射可以带来短期缓解,但这种缓解常常在六周后出现逆转,而且问题经常复发 [3]。研究表明,对于网球肘症状持续不到12个月的大多数人,不应使用类固醇 [8]。对于腕管综合征,注射可以安全有效地暂时缓解症状,但大多数人最终需要手术才能长期控制病情 [2]。

在选择这种治疗之前,有一些研究结果值得了解。对于扳机指,一种类固醇(倍他米松)比另一种(曲安奈德)更早失效 [9]。对于肩袖修复,没有明确迹象表明类固醇注射会增加修复再次失败或感染的风险 [10]。在肩袖手术前1年内进行的单次注射,并没有改变修复失败率、患者自评结果、活动范围或力量 [11]。

这些证据并不完美。其中一些结果来自小型试验或综述,而且有几种病症可供参考的研究很有限。医生会权衡与您具体病症相关的证据,并和您讨论注射是否可能对您有帮助,或者是否应先尝试其他方案。

风险有哪些?

大多数人只会在注射部位感到短期的影响。注射本身可能会疼,而在类固醇中加入局部麻醉药(利多卡因),会改变您在注射时和注射后不久感受到的疼痛程度 [12]。从长远来看,这种差异可能影响不大,但值得在注射前询问。

类固醇也可能影响注射部位的组织。对于网球肘,研究发现类固醇注射与软组织内钙质沉积有关,而这很可能是注射本身引起的并发症 [13]。对于某些接受网球肘治疗的人,单次类固醇注射导致长期效果较差,1年后问题复发也更为常见 [14]。

药物的作用可能超出注射部位。如果您患有2型糖尿病且不使用胰岛素,肩部类固醇注射可能会使您的血糖水平短时间升高 [15]。如果您患有糖尿病并正在接受狭窄性腱鞘炎(de Quervain病)的治疗,单次注射对您有效的可能性低于没有糖尿病的人,不过再次注射似乎并不会失去效果 [16]。

有些您可能担心的风险已经过研究,并未被发现。在肩袖修复术后,研究没有发现明确证据表明类固醇注射会增加修复再次撕裂或感染的风险 [10]。腕管松解手术前进行类固醇注射,与术后深部感染率升高无关 [17]。针对腕管综合征的重复注射被证明是安全的,也不会增加日后手术的风险 [18]。

注射的频率也很重要。对于扳机指,一项研究发现,以至少间隔1个月的频率注射4 mg曲安奈德,没有出现并发症 [19]。对于狭窄性腱鞘炎(de Quervain病),针对单个肌腱间室进行注射可以减少类固醇用量,这可能会减少并发症 [20]。

这适合您吗?

如果您的疼痛来自一个明确的部位,例如扳机指、拇指根部关节炎或冻结肩,注射可能适合您。对于拇指根部关节炎(拇指根部的磨损性关节炎),研究支持使用类固醇注射,因为它操作简便、效果良好 [6]。如果您患有腕管综合征,而之前的注射效果不能持久,重复注射已被证明是安全的,也不会增加日后手术的风险 [18]。

如果您的网球肘症状持续不到12个月,注射可能不适合您。研究表明,对于这种情况下的大多数人,不应使用类固醇 [8]。对于一般的网球肘,富血小板血浆(用您自己的血液制成的一种治疗)在6个月时的效果优于类固醇注射,而类固醇在第一个月内效果更好 [21]。

这是您和医生共同做出的选择。医生会考虑您的病症、症状以及您已经尝试过的治疗。请询问注射的目的是什么、缓解效果可能持续多久,以及锻炼、支具或手术是否会更适合您。上面的风险部分详细介绍了副作用,请在做决定前阅读。

核心要点

对于明确的单一部位问题,例如冻结肩、狭窄性腱鞘炎(de Quervain病)或拇指根部关节炎,可的松注射值得考虑。缓解效果可能是真实的,但往往是短期的;同时要知道,对于某些病症,例如网球肘或腕管综合征,从长远来看,其他治疗或手术可能更适合您。最需要注意的一点是:注射只能缓解症状,并不能解决根本问题。


References
  1. Corticosteroid Injections After Rotator Cuff Repair Improve Function, Reduce Pain, and Are Safe: A Systematic Review. *Arthroscopy, Sports Medicine, and Rehabilitation*. 2021. 10.1016/j.asmr.2021.10.010
  2. Corticosteroid Injection for Carpal Tunnel Syndrome. *The Journal of Hand Surgery*. 2008. 10.1016/j.jhsa.2008.06.023
  3. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. *BMJ*. 2006. 10.1136/bmj.38961.584653.ae
  4. Intra-articular Steroid Injection for Frozen Shoulder: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis. *The American Journal of Sports Medicine*. 2016. 10.1177/0363546516669944
  5. Prospective randomized comparison of ultrasonography-guided and blind corticosteroid injection for de Quervain's disease. *Orthopaedics & Traumatology: Surgery & Research*. 2020. 10.1016/j.otsr.2019.11.015
  6. Efficacy of Intra-Articular Corticosteroid Injection for Nonsurgical Management of Trapeziometacarpal Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. *The Journal of Hand Surgery*. 2024. 10.1016/j.jhsa.2024.02.001
  7. Intra-Articular Corticosteroid Injections to Manage Trapeziometacarpal Osteoarthritis—a Systematic Review. *HAND*. 2015. 10.1007/s11552-015-9778-3
  8. Stop injecting corticosteroid into patients with tennis elbow, they are much more likely to get better by themselves!. *Journal of Science and Medicine in Sport*. 2010. 10.1016/j.jsams.2009.09.009
  9. The Effect of Corticosteroid Type on Failure Following Primary Trigger Finger Injection. *The Journal of Hand Surgery*. 2026. 10.1016/j.jhsa.2026.03.011
  10. Do Corticosteroid Injections Before or After Primary Rotator Cuff Repair Influence the Incidence of Adverse Events? A Subjective Synthesis. *Arthroscopy*. 2020. 10.1016/j.arthro.2020.01.039
  11. Timing of corticosteroid injection within 1 year prior to rotator cuff repair was not associated with increased risk of repair failure. *JSES International*. 2026. 10.1016/j.jseint.2026.101632
  12. Corticosteroid Injection With and Without Local Anesthetic for the Treatment of Trigger Finger: A Randomized Clinical Trial. *The Journal of Hand Surgery*. 2025. 10.1016/j.jhsa.2024.05.016
  13. Association of steroid injection with soft-tissue calcification in lateral epicondylitis. *Journal of Shoulder and Elbow Surgery*. 2019. 10.1016/j.jse.2018.10.009
  14. Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral Epicondylalgia. *JAMA*. 2013. 10.1001/jama.2013.129
  15. The effect of steroid injection into the shoulder on glycemia in patients with type 2 diabetes. *JSES International*. 2022. 10.1016/j.jseint.2022.05.016
  16. Effectiveness of Corticosteroid Injections in Diabetic Patients With De Quervain Tenosynovitis. *The Journal of Hand Surgery*. 2022. 10.1016/j.jhsa.2022.02.018
  17. Ipsilateral Preoperative Corticosteroid Injection and Timing Not Associated With Postoperative Deep Infection After Carpal Tunnel Release. *Journal of the American Academy of Orthopaedic Surgeons*. 2025. 10.5435/jaaos-d-25-00317
  18. The safety and cost of repeated corticosteroid injections for carpal tunnel syndrome. *Journal of Hand Surgery (European Volume)*. 2025. 10.1177/17531934251396629
  19. Safety and Efficacy of Low-Dose Triamcinolone Injection without Injection Frequency Limitation for Trigger Finger. *Journal of Hand Surgery Global Online*. 2025. 10.1016/j.jhsg.2025.01.005
  20. Is a Steroid Injection in Both Compartments More Effective than an Injection in the Extensor Pollicis Brevis Subcompartment Alone in Patients with de Quervain Disease? A Randomized, Controlled Trial. *Clinical Orthopaedics & Related Research*. 2021. 10.1097/corr.0000000000002018
  21. Corticosteroid injections for the treatment of lateral epicondylitis are superior to platelet-rich plasma at 1 month but platelet-rich plasma is more effective at 6 months: an updated systematic review and meta-analysis of level 1 and 2 studies. *Journal of Shoulder and Elbow Surgery*. 2023. 10.1016/j.jse.2023.04.018
Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

Efficacy by Condition

  • Corticosteroid injections are effective in 57% of patients with trigger finger [10].
  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores in rotator cuff repair patients [3].
  • Corticosteroids are a favorable option for the management of trapeziometacarpal osteoarthritis given their affordability, ease of administration, and efficacy [11].
  • When corticosteroid injection is used to treat adhesive capsulitis, both intra-articular and subacromial injection sites can be selected [15].

Steroid Type and Dosing

  • Betamethasone injections resulted in a significantly shorter time to failure than triamcinolone injections for primary trigger finger [1].
  • Triamcinolone is supported as a more viable corticosteroid option for shoulder injection compared to methylprednisolone [4].
  • An injection targeting the extensor pollicis brevis subcompartment alone in de Quervain disease can reduce the dose of steroids used, potentially decreasing complications [8].
  • No complications were observed for 4 mg triamcinolone injections for trigger finger when administered at intervals of at least 1 month [12].

Safety and Timing

  • Corticosteroid injections should be administered only after the first postoperative month following rotator cuff repair to minimize the potential risk for adverse events [2].
  • An interval of at least three months is recommended between corticosteroid injection and shoulder arthroplasty [19].
  • There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use based on a subjective synthesis of ranges [5].

Contraindications

  • Corticosteroid injections should not be used to treat most patients with tennis elbow with symptom duration of less than 12 months [6].

How It Works

Efficacy and Outcomes by Condition

  • Local corticosteroid injection provides greater clinical improvement in symptoms 1 month after injection compared with placebo for carpal tunnel syndrome [13].
  • Local corticosteroid injection provides significantly greater improvement than oral corticosteroid for up to 3 months for carpal tunnel syndrome [13].
  • Local corticosteroid injection does not significantly improve outcomes compared with anti-inflammatory treatment, splinting, or laser treatment beyond 8 weeks for carpal tunnel syndrome [13].
  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores after rotator cuff repair [3].
  • The significant short term benefits of corticosteroid injection for tennis elbow are reversed after six weeks, with high recurrence rates [9].
  • Combining a corticosteroid injection with exercise is not superior to exercise or no exercise for plantar fasciopathy [7].

Steroid Type and Dosing

  • An injection targeting the extensor pollicis brevis subcompartment alone can reduce the dose of steroids used in de Quervain disease [8].

Safety and Complications

  • No complications were observed for 4 mg triamcinolone injections when administered at intervals of at least 1 month for trigger finger [12].
  • Local corticosteroid injection to the shoulder can create a significant, short-term increase in systemic glucose levels in patients with type 2 diabetes not treated with insulin [20].
  • Serial saline solution injections are a promising, cost-effective, and low-risk treatment option for subcutaneous lipoatrophy and skin depigmentation following cortisone injection in the elbow [17].

Timing and Surgical Context

  • Corticosteroid injections should be administered only after the first postoperative month to minimize the potential risk for adverse events following rotator cuff repair [2].
  • Preoperative corticosteroid injection at all studied timepoints was not associated with an increased risk of postoperative deep infection after carpal tunnel release [16].

Contraindications and Cautions

  • Corticosteroid injection for tennis elbow should be used with caution due to high recurrence rates after six weeks [9].

What the Evidence Shows

Trigger Finger

  • Betamethasone injections resulted in a significantly shorter time to failure than triamcinolone injections [1].
  • There is a statistically significant difference in pain during and shortly after injection when using a steroid with lidocaine versus steroid alone, but that difference may not be clinically relevant [27].

Lateral Epicondylitis (Tennis Elbow)

  • The significant short term benefits of corticosteroid injection are paradoxically reversed after six weeks, with high recurrence rates, implying that this treatment should be used with caution in the management of tennis elbow [9].
  • A single, blinded injection of corticosteroid medication was associated with poorer long-term outcomes and higher recurrence rates 1 year after receiving an injection in patients with unilateral lateral epicondylalgia [22].
  • Corticosteroid injections for the treatment of lateral epicondylitis are superior to platelet-rich plasma at 1 month [18].
  • Platelet-rich plasma is more effective than corticosteroid injections at 6 months for the treatment of lateral epicondylitis [18].
  • Platelet-rich plasma is superior to corticosteroid injections at 3 months for the treatment of lateral epicondylitis [18].

Rotator Cuff

  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores in rotator cuff disease [3].
  • There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use based on a subjective synthesis of ranges regarding rotator cuff repair [5].
  • Timing of a single preoperative corticosteroid injection within 1 year of rotator cuff repair did not significantly affect failure rates, patient-reported outcomes, range of motion, or strength [26].
  • Corticosteroids have better efficacy in short term for rotator cuff disease treatment compared to platelet-rich plasma [23].
  • Platelet-rich plasma is more beneficial for longterm recovery in rotator cuff disease treatment compared to corticosteroids [23].

Shoulder (General)

  • Intra-articular steroid injection is effective and safe for frozen shoulder, relieving pain, improving functional performance, and increasing range of motion [25].

Carpal Tunnel Syndrome

  • Local corticosteroid injection provides greater clinical improvement in symptoms 1 month after injection compared with placebo [13].
  • Corticosteroid injection is safe and effective for the temporary relief of carpal tunnel syndrome symptoms [24].
  • Most patients with carpal tunnel syndrome will eventually require surgery for long-term control of their symptoms despite corticosteroid injection [24].

Thumb Carpometacarpal Joint

  • Corticosteroids are a favorable option when considering the choice of intra-articular injection for the management of trapeziometacarpal osteoarthritis given their affordability, ease of administration, and efficacy [11].
  • There is lack of robust evidence to support use of image guidance to improve accuracy and clinical effectiveness of steroid injection for thumb carpometacarpal joint osteoarthritis [14].

Plantar Fasciopathy

  • Combining a corticosteroid injection with exercise is not superior to exercise or no exercise for patients with plantar fasciopathy [7].

Practical Considerations

Steroid Selection and Dosing

  • An injection targeting the extensor pollicis brevis subcompartment alone in de Quervain disease can reduce the dose of steroids used, potentially decreasing complications related to steroid injections [8].

Timing and Frequency

  • Corticosteroid injections after rotator cuff repair should be administered only after the first postoperative month to minimize the potential risk for adverse events [2].

Efficacy and Outcomes

  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores following rotator cuff repair [3].
  • Combining a corticosteroid injection with exercise for plantar fasciopathy is not superior to exercise or no exercise [7].
  • Corticosteroids are a favorable option for intra-articular injection in the management of trapeziometacarpal osteoarthritis given their affordability, ease of administration, and efficacy [11].
  • Platelet-rich plasma has no advantage over steroid injections within the first month of treatment for lateral epicondylitis, but it is superior to steroids at both 3 and 6 months [18].

Safety and Complications

  • There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use before or after primary rotator cuff repair based on a subjective synthesis of ranges [5].
  • Corticosteroid and hyaluronic acid injections remain a safe treatment option regarding the risk of severe adverse events requiring hospitalization [21].

Imaging Guidance

  • There is a lack of robust evidence to support the use of image guidance to improve accuracy and clinical effectiveness of steroid injection for thumb carpometacarpal joint osteoarthritis [14].

Key Evidence

  • [L3] Betamethasone injections resulted in a significantly shorter time to failure than triamcinolone injections. [1] (10.1016/j.jhsa.2026.03.011)
  • [L1] Corticosteroid injections should be administered only after the first postoperative month to minimize the potential risk for adverse events. [2] (10.1016/j.asmr.2021.10.010)
  • [L4] Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores. [3] (10.1016/j.arthro.2020.04.044)
  • [L2] This study supports TA as a more viable corticosteroid option for shoulder injection. [4] (10.1016/j.jse.2023.05.023)
  • [L3] There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use based on a subjective synthesis of ranges. [5] (10.1016/j.arthro.2020.01.039)
  • [Paper] Corticosteroid injections should not be used to treat most patients with tennis elbow with symptom duration of less than 12 months. [6] (10.1016/j.jsams.2009.09.009)
  • [L1] The results indicate that combining a corticosteroid injection with exercise is not superior to exercise or no exercise. [7] (10.1136/bjsports-2023-106948)
  • [L1] An injection targeting the EPB subcompartment alone can reduce the dose of steroids used, perhaps thereby decreasing complications related to steroid injections. [8] (10.1097/corr.0000000000002018)
  • [L1] The significant short term benefits of corticosteroid injection are paradoxically reversed after six weeks, with high recurrence rates, implying that this treatment should be used with caution in the management of tennis elbow. [9] (10.1136/bmj.38961.584653.ae)
  • [L1] Corticosteroid injections are effective in 57% of patients with trigger finger. [10] (10.5435/00124635-200703000-00006)
  • [L1] Given the affordability, ease of administration, and efficacy associated with corticosteroids, they are a favorable option when considering the choice of intra-articular injection for the management of TMC OA. [11] (10.1016/j.jhsa.2024.02.001)
  • [L4] No complications were observed for 4 mg triamcinolone injections when administered at intervals of at least 1 month. [12] (10.1016/j.jhsg.2025.01.005)
  • [L1] Local corticosteroid injection provides greater clinical improvement in symptoms 1 month after injection compared with placebo and significantly greater improvement than oral corticosteroid for up to 3 months, but does not significantly improve outcomes compared with anti-inflammatory treatment, splinting, or laser treatment beyond 8 weeks. [13] (10.1177/1753193413490848)
  • [L4] However, there is lack of robust evidence to support use of image guidance to improve accuracy and clinical effectiveness of steroid injection for thumb CMCJ and warrants further research. [14] (10.1177/17589983261430876)
  • [L1] When corticosteroid injection is used to treat adhesive capsulitis, both injection sites can be selected. [15] (10.1155/2019/1274790)
  • [L3] Preoperative corticosteroid injection at all studied timepoints was not associated with an increased risk of postoperative deep infection, a divergence from existing literature. [16] (10.5435/jaaos-d-25-00317)
  • [L4] Serial saline solution injections are a promising, cost-effective, and low-risk treatment option for subcutaneous lipoatrophy and skin depigmentation following cortisone injection in the elbow. [17] (10.1016/j.jseint.2020.08.009)
  • [L1] PRP has no advantage over steroid injections within the first month of treatment, but it is superior to steroids at both 3 and 6 months. [18] (10.1016/j.jse.2023.04.018)
  • [L1] Thus, an interval of at least three months is recommended between injection and arthroplasty. [19] (10.1177/17585732241261659)
  • [L2] Local corticosteroid injection to the shoulder can create a significant, short-term increase in systemic glucose levels in patients with type 2 diabetes not treated with insulin. [20] (10.1016/j.jseint.2022.05.016)
  • [L2] Corticosteroid and hyaluronic acid injections remain a safe treatment option regarding the risk of severe adverse events requiring hospitalization. [21] (10.1186/s12891-026-09752-7)
  • [L1] A single, blinded injection of corticosteroid medication was associated with poorer long-term outcomes and higher recurrence rates 1 year after receiving an injection in patients with unilateral lateral epicondylalgia. [22] (10.1001/jama.2013.129)
  • [L1] Current analysis showed that corticosteroids have better efficacy in short term, whereas PRP is more beneficial for longterm recovery. [23] (10.1016/j.jse.2023.01.037)
  • [L5] Corticosteroid injection is safe and effective for the temporary relief of carpal tunnel syndrome symptoms, but most patients will eventually require surgery for long-term control of their symptoms. [24] (10.1016/j.jhsa.2008.06.023)
  • [L1] Intra-articular steroid injection is effective and safe for frozen shoulder, relieving pain, improving functional performance, and increasing range of motion. [25] (10.1177/0363546516669944)
  • [L2] Timing of a single preoperative corticosteroid injection within 1 year of rotator cuff repair did not significantly affect failure rates, patient-reported outcomes, range of motion, or strength, suggesting that one injection before repair does not strongly influence outcomes. [26] (10.1016/j.jseint.2026.101632)
  • [L2] There is a statistically significant difference in pain during and shortly after injection when using a steroid with lidocaine versus steroid alone, but that difference may not be clinically relevant. [27] (10.1016/j.jhsa.2024.05.016)

References

[1] The Effect of Corticosteroid Type on Failure Following Primary Trigger Finger Injection. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2026.03.011

[2] Corticosteroid Injections After Rotator Cuff Repair Improve Function, Reduce Pain, and Are Safe: A Systematic Review. Arthroscopy, Sports Medicine, and Rehabilitation. 2021. DOI: 10.1016/j.asmr.2021.10.010

[3] Corticosteroid Injections May Increase Retear and Revision Rates of Rotator Cuff Repair: A Systematic Review. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.04.044

[4] Comparison of triamcinolone and methylprednisolone efficacy and steroid flare reaction rates after shoulder corticosteroid injection: a prospective interrupted time series study. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.05.023

[5] Do Corticosteroid Injections Before or After Primary Rotator Cuff Repair Influence the Incidence of Adverse Events? A Subjective Synthesis. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.01.039

[6] Stop injecting corticosteroid into patients with tennis elbow, they are much more likely to get better by themselves!. Journal of Science and Medicine in Sport. 2010. DOI: 10.1016/j.jsams.2009.09.009

[7] Does a corticosteroid injection plus exercise or exercise alone add to the effect of patient advice and a heel cup for patients with plantar fasciopathy? A randomised clinical trial. British Journal of Sports Medicine. 2023. DOI: 10.1136/bjsports-2023-106948

[8] Is a Steroid Injection in Both Compartments More Effective than an Injection in the Extensor Pollicis Brevis Subcompartment Alone in Patients with de Quervain Disease? A Randomized, Controlled Trial. Clinical Orthopaedics & Related Research. 2021. DOI: 10.1097/corr.0000000000002018

[9] Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006. DOI: 10.1136/bmj.38961.584653.ae

[10] Corticosteroid Injections in the Treatment of Trigger Finger: A Level I and II Systematic Review. Journal of the American Academy of Orthopaedic Surgeons. 2007. DOI: 10.5435/00124635-200703000-00006

[11] Efficacy of Intra-Articular Corticosteroid Injection for Nonsurgical Management of Trapeziometacarpal Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2024.02.001

[12] Safety and Efficacy of Low-Dose Triamcinolone Injection without Injection Frequency Limitation for Trigger Finger. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.01.005

[13] Cochrane corner: local corticosteroid injection for carpal tunnel syndrome. Journal of Hand Surgery (European Volume). 2013. DOI: 10.1177/1753193413490848

[14] Guided steroid injection for thumb carpometacarpal joint (CMCJ) osteoarthritis: A scoping review. Hand Therapy. 2026. DOI: 10.1177/17589983261430876

[15] Intra-Articular versus Subacromial Corticosteroid Injection for the Treatment of Adhesive Capsulitis: A Meta-Analysis and Systematic Review. BioMed Research International. 2019. DOI: 10.1155/2019/1274790

[16] Ipsilateral Preoperative Corticosteroid Injection and Timing Not Associated With Postoperative Deep Infection After Carpal Tunnel Release. Journal of the American Academy of Orthopaedic Surgeons. 2025. DOI: 10.5435/jaaos-d-25-00317

[17] Serial saline solution injections for the treatment of lipoatrophy and depigmentation after corticosteroid injection for medial epicondylitis. JSES International. 2020. DOI: 10.1016/j.jseint.2020.08.009

[18] Corticosteroid injections for the treatment of lateral epicondylitis are superior to platelet-rich plasma at 1 month but platelet-rich plasma is more effective at 6 months: an updated systematic review and meta-analysis of level 1 and 2 studies. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.04.018

[19] The safety of corticosteroid injection prior to shoulder arthroplasty: A systematic review. Shoulder & Elbow. 2024. DOI: 10.1177/17585732241261659

[20] The effect of steroid injection into the shoulder on glycemia in patients with type 2 diabetes. JSES International. 2022. DOI: 10.1016/j.jseint.2022.05.016

[21] Safety of intra-articular corticosteroid and hyaluronic acid injections: a 14-year population-based cohort study of 404,797 patients. BMC Musculoskeletal Disorders. 2026. DOI: 10.1186/s12891-026-09752-7

[22] Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral Epicondylalgia. JAMA. 2013. DOI: 10.1001/jama.2013.129

[23] Comparison of the effects of platelet-rich plasma and corticosteroid injection in rotator cuff disease treatment: a systematic review and meta-analysis. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.01.037

[24] Corticosteroid Injection for Carpal Tunnel Syndrome. The Journal of Hand Surgery. 2008. DOI: 10.1016/j.jhsa.2008.06.023

[25] Intra-articular Steroid Injection for Frozen Shoulder: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516669944

[26] Timing of corticosteroid injection within 1 year prior to rotator cuff repair was not associated with increased risk of repair failure. JSES International. 2026. DOI: 10.1016/j.jseint.2026.101632

[27] Corticosteroid Injection With and Without Local Anesthetic for the Treatment of Trigger Finger: A Randomized Clinical Trial. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.05.016